-
Sector Analysis
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Breast cancer (BC) is a type of cancer that forms in breast cells, which grow and divide in an uncontrolled way, creating a mass of tissue called a tumor. Like other forms of cancer, BC can invade and grow into the tissue surrounding the breast. It can also travel to other parts of the body and form new tumors in a process called tumor metastasis. BC is one of the most common cancers diagnosed among women and is more likely...
-
Thematic Analysis
Digital Marketing Trends in Hepatocellular Carcinoma
Merck & Co.’s Keytruda com achieved the highest traffic across US hepatocellular carcinoma (HCC) patient sites, with 2.1 million visits from August 2021 to July 2022. This was followed by Bristol Myers Squibb's  (BMS) Opdivo.com (1.2 million visits) and Genentech's Tecentriq com (497,000 visits). The highest proportion of traffic to these sites originated from direct sources, followed by organic and referral traffic. The digital marketing trends in hepatocellular carcinoma research report will help to understand the digital marketing competitive landscape...
-
Sector Analysis
Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule. RCC is the most common type of kidney cancer in adults. While it is considered one of the most lethal urological cancers, the causes of RCC are largely unknown. The most important known etiological risk factors, all of which are modifiable, are tobacco use, high blood pressure, and obesity. The renal cell carcinoma marketed and pipeline drugs market report provides...
-
Product Insights
Dedifferentiated Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Dedifferentiated Liposarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Dedifferentiated Liposarcoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dedifferentiated Liposarcoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Malignant Neoplasms Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Malignant Neoplasms Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Malignant Neoplasms pipeline landscape. The report provides comprehensive information on the therapeutics under development for Malignant Neoplasms, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Oral Cavity (Mouth) Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Oral Cavity (Mouth) Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Oral Cavity (Mouth) Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Oral Cavity (Mouth) Cancer, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history...
-
Product Insights
Thymic Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Thymic Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Thymic Carcinoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Thymic Carcinoma, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) pipeline landscape. The report provides comprehensive information on the therapeutics under development for T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the...
-
Product Insights
Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Biliary Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Biliary Tumor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Biliary Tumor, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.